The following video is from Friday's Motley Fool Money roundtable discussion with host Chris Hill and analysts Ron Gross, James Early, and Charly Travers.
Intuitive Surgical (NASDAQ:ISRG) reported double-digit sales growth and that first-quarter profits rose 32%. Despite the strong quarter, shares fell on Friday. In this segment, our analysts talk about Intuitive Surgical's business and how big a red flag the company's FDA investigation is for investors.
The relevant video segment can be found between 14:25 and 15:56.
Charly Travers, Chris Hill, James Early, and Ron Gross have no position in any stocks mentioned. The Motley Fool recommends and owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Earnings: 2 Hot Stocks to Watch Next Week
These two stocks have soared in the past 12 months. Can they continue to impress investors?
Here's How Intuitive Surgical, Inc. Crushed It in 2017
2017 was a banner year for the leader in robotic surgery. Look and see why investors couldn't have asked for much more.
Guess Who Wants to Kill This Hated Obamacare Tax
Hint: They're not Republicans.